Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-04-24, Stock:ABBV, The news for the past five days is as follows:
2019-04-16: NEWS1: J&J (JNJ) Beats on Q1 Earnings, Ups 2019 Sales Growth View.NEWS2: J&J (JNJ) Beats on Q1 Earnings, Ups 2019 Sales Growth View.NEWS3: Is AbbVie Stock An Undiscovered Cannabis Play Waiting For Some Attention?.NEWS4: J&J (JNJ) Beats on Q1 Earnings, Ups 2019 Sales Growth View.NEWS5: Is AbbVie Stock An Undiscovered Cannabis Play Waiting For Some Attention?.NEWS6: AbbVie (ABBV) Gains As Market Dips: What You Should Know.
2019-04-17: NEWS1: AbbVie Falls 3%.NEWS2: Is TG Therapeutics a Buy?.NEWS3: Is TG Therapeutics a Buy?.
2019-04-18: NEWS1: AbbVie (ABBV) Earnings Expected to Grow: Should You Buy?.NEWS2: AbbVie (ABBV) Earnings Expected to Grow: Should You Buy?.NEWS3: Can Q1 Earnings Lift Healthcare ETFs Higher?.NEWS4: Can Q1 Earnings Lift Healthcare ETFs Higher?.NEWS5: Here Are the Key Takeaways From J&J's Q1 Earnings Report.NEWS6: Here Are the Key Takeaways From J&J's Q1 Earnings Report.NEWS7: Can Q1 Earnings Lift Healthcare ETFs Higher?.NEWS8: AbbVie (ABBV) Earnings Expected to Grow: Should You Buy?.NEWS9: Here Are the Key Takeaways From J&J's Q1 Earnings Report.NEWS10: Health Canada Approves SKYRIZI™ (risankizumab) for the Treatment of Moderate to Severe Plaque Psoriasis.
2019-04-22: NEWS1: Better Buy: Biogen vs. AbbVie.NEWS2: Better Buy: Biogen vs. AbbVie.NEWS3: Better Buy: Biogen vs. AbbVie.NEWS4: Is a Beat in Store for AbbVie (ABBV) This Earnings Season?.NEWS5: Is a Beat in Store for AbbVie (ABBV) This Earnings Season?.NEWS6: Biogen (BIIB) to Report Q1 Earnings: What's in the Cards?.NEWS7: Biogen (BIIB) to Report Q1 Earnings: What's in the Cards?.NEWS8: Notable ETF Outflow Detected - IYH, ABBV, AMGN, MDT.NEWS9: Notable ETF Outflow Detected - IYH, ABBV, AMGN, MDT.NEWS10: Is a Beat in Store for AbbVie (ABBV) This Earnings Season?.NEWS11: Biogen (BIIB) to Report Q1 Earnings: What's in the Cards?.NEWS12: AbbVie Reports Its Q1 Results on Thursday: Here's What You Can Expect.NEWS13: AbbVie Reports Its Q1 Results on Thursday: Here's What You Can Expect.NEWS14: AbbVie Reports Its Q1 Results on Thursday: Here&apos;s What You Can Expect.
2019-04-23: NEWS1: AbbVie's Skyrizi drug to treat psoriasis wins U.S. approval.NEWS2: AbbVie stock ticks higher on FDA approval of psoriasis treatment.NEWS3: AbbVie Expands Immunology Portfolio in the U.S. with FDA Approval of SKYRIZI™ (risankizumab-rzaa) for Moderate to Severe Plaque Psoriasis.NEWS4: You can find plenty of solid stock bargains in this year’s worst-performing sector, analyst says.NEWS5: Analysts see plenty of attractive bargains in this year’s worst-performing stock sector.

Answer: Rise